DONNA DOERFFLER: Open Payments
NPI 1467711705 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,601 in 171 payments from 25 companies in 2025. Trend: 2023 $2,476 · 2024 $2,114 · 2025 $3,601
Food & beverage: $3,567Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $652 |
| GlaxoSmithKline, LLC. | 31 | $380 |
| GENZYME CORPORATION | 9 | $326 |
| CSL Behring | 12 | $284 |
| Verona Pharma, Inc. | 19 | $260 |
| PFIZER INC. | 14 | $206 |
| Grifols USA, LLC | 4 | $170 |
| Galderma Laboratories, L.P. | 3 | $168 |
| Regeneron Healthcare Solutions, Inc. | 7 | $167 |
| ABBVIE INC. | 15 | $136 |
Products named: DUPIXENT, TEZSPIRE, Ohtuvayre, TRELEGY ELLIPTA, AIRSUPRA, NURTEC ODT, NEMLUVIO, FASENRA.
Industry payments across IN — which companies pay providers there.
